Savient Pharmaceuticals (SVNT) Posts Q3 Loss of 56c/Share
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Financial Fact:
Selling, general and administrative: 14.32M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 14.32M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q3 EPS of ($0.56), $0.08 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $5.85 million.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
